Literature DB >> 21727753

Improving quality of care and outcomes for heart failure. -Role of registries-.

Gregg C Fonarow1.   

Abstract

Heart failure (HF) results in substantial morbidity, mortality, and costs, yet quality of care varies widely and is frequently inadequate. Performance improvement registries have been developed to improve the quality of care and outcomes for patients with HF in both the inpatient and outpatient settings. HF registries in the United States include ADHERE, OPTIMIZE-HF, GWTG-HF, and IMPROVE HF. These registries collect data on clinical characteristics, admission, hospital, discharge, and/or outpatient care, as well as outcomes. Web-based tools that provide real-time feedback of performance and other quality measures benchmarked to other sites and national data are frequently utilized. Process-of-care improvement tools, including evidence-based clinical decision support, customizable order sets, and patient education are also used. Participation in performance improvement registries has been associated with substantial improvements in the use of guideline-recommended therapies for HF in both the inpatient and outpatient settings. Conformity with HF quality measures has also been shown to improve and disparities in care have also been reduced or eliminated. There have also been improvements in clinical outcomes. This paper reviews the evidence that participation in HF performance improvement registries is associated with improved use of guideline-recommended HF therapies, better conformity with quality measures, and improved outcomes in patients with HF.

Entities:  

Mesh:

Year:  2011        PMID: 21727753     DOI: 10.1253/circj.cj-11-0582

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  13 in total

1.  Prognostic value of leucine/phenylalanine ratio as an amino acid profile of heart failure.

Authors:  Hiroaki Hiraiwa; Takahiro Okumura; Toru Kondo; Toshiaki Kato; Shingo Kazama; Yuki Kimura; Toshikazu Ishihara; Etsuo Iwata; Masafumi Shimojo; Sayano Kondo; Soichiro Aoki; Yasunori Kanzaki; Daisuke Tanimura; Hiroaki Sano; Yoshifumi Awaji; Sumio Yamada; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2021-01-22       Impact factor: 2.037

2.  Advanced Heart Failure Epidemiology and Outcomes: A Population-Based Study.

Authors:  Shannon M Dunlay; Véronique L Roger; Jill M Killian; Susan A Weston; Philip J Schulte; Anna V Subramaniam; Saul B Blecker; Margaret M Redfield
Journal:  JACC Heart Fail       Date:  2021-08-11       Impact factor: 12.544

3.  Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions.

Authors:  Mihai Gheorghiade; Muthiah Vaduganathan; Stephen J Greene; Robert J Mentz; Kirkwood F Adams; Stefan D Anker; Malcolm Arnold; Fabio Baschiera; John G F Cleland; Gadi Cotter; Gregg C Fonarow; Christopher Giordano; Marco Metra; Frank Misselwitz; Eva Mühlhofer; Savina Nodari; W Frank Peacock; Burkert M Pieske; Hani N Sabbah; Naoki Sato; Monica R Shah; Norman L Stockbridge; John R Teerlink; Dirk J van Veldhuisen; Andrew Zalewski; Faiez Zannad; Javed Butler
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

4.  Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry.

Authors:  W von Scheidt; C Zugck; M Pauschinger; R Hambrecht; O Bruder; A Hartmann; M Rauchhaus; R Zahn; J Brachmann; U Tebbe; T Neumann; R H Strasser; M Böhm; S Störk; M Hochadel; P Heidemann; J Senges
Journal:  Clin Res Cardiol       Date:  2014-07-23       Impact factor: 5.460

5.  Chronic Heart Failure Clinical Practice Guidelines' Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?

Authors:  Ramon F Abarquez; Paul Ferdinand M Reganit; Carmen N Chungunco; Jean Alcover; Felix Eduardo R Punzalan; Eugenio B Reyes; Elleen L Cunanan
Journal:  ASEAN Heart J       Date:  2016-03-08

6.  Effect of a do-not-resuscitate order on the quality of care in acute heart failure patients: a single-center cohort study.

Authors:  Shunsuke Kojima; Eiji Hiraoka; Junya Arai; Yosuke Homma; Yasuhiro Norisue; Osamu Takahashi; Taihei Soma; Toshihiko Suzuki; Masahiko Noguchi; Kentaro Shibayama; Kotaro Obunai; Hiroyuki Watanabe
Journal:  Int J Gen Med       Date:  2018-10-16

7.  SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World (SUGAR): a multi-center, retrospective, observational study.

Authors:  Byung-Su Yoo; Jaewon Oh; Bum-Kee Hong; Dae-Hee Shin; Jang-Ho Bae; Dong Heon Yang; Wan-Joo Shim; Hyung-Seop Kim; Su-Hong Kim; Jin-Oh Choi; Woo-Jung Chun; Choong-Won Go; Hyun-Jae Kang; Sang Hong Baek; Jang-Hyun Cho; Suk-Keun Hong; Joon-Han Shin; Seok-Kyu Oh; Wook-Bum Pyun; Jun Kwan; Young-Joon Hong; Jin-Ok Jeong; Seok-Min Kang; Dong-Ju Choi
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

8.  Trends in quality of care among patients with incident heart failure in Denmark 2003-2010: a nationwide cohort study.

Authors:  Anne Nakano; Søren Paaske Johnsen; Birgitte Lidegaard Frederiksen; Marie Louise Svendsen; Carsten Agger; Inge Schjødt; Kenneth Egstrup
Journal:  BMC Health Serv Res       Date:  2013-10-05       Impact factor: 2.655

Review 9.  Chronic heart failure: we are fighting the battle, but are we winning the war?

Authors:  John J Atherton
Journal:  Scientifica (Cairo)       Date:  2012-12-20

10.  Signs, symptoms, and treatment patterns across serial ambulatory cardiology visits in patients with heart failure: insights from the NCDR PINNACLE® registry.

Authors:  Larry A Allen; Fengming Tang; Philip Jones; Tracie Breeding; Angelo Ponirakis; Stuart J Turner
Journal:  BMC Cardiovasc Disord       Date:  2018-05-03       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.